OVARIAN CANCER CANADA/CANCER DE L'OVAIRE CANADA
Charitable organizationCore health care·316 - 4211 YONGE ST · NORTH YORK, ON · M2P 2A9·BN 872974845RR0001·website ↗
Last reported: F2024 filing · period ending 2024-03-31
Cents to cause T1
58¢
of each dollar spent, to programs
Operating overhead T1
42%
typical range 5–35%
Reserves T1
0.7 yr
of program spending, in cash and investments
Revenue T1
$6.4M
Charity Intelligence ★★★★ · T2
— means the filing doesn't include the lines needed; details and sources below.·How to read these figures
Common questions
How do I donate to Ovarian Cancer Canada?
You can search for it on CanadaHelps or give directly through its own website. Charity Compass never handles your money — we only link out to where you can give.
Is Ovarian Cancer Canada a registered charity?
Per CRA records, it filed a F2024 T3010 return under charity number 872974845RR0001. Registration status can change, so check the CRA charities listing for its current status. Only a currently registered charity can issue an official donation receipt.
Where is Ovarian Cancer Canada located?
Per its F2024 T3010, its address on file is 316 - 4211 YONGE ST, NORTH YORK, ON, M2P 2A9. Source.
What does Ovarian Cancer Canada do?
In its own words, from its F2024 T3010 filing: "Research: Investing in pan-Canadian and patient-centered research across the full continuum of ovarian cancer from prevention to diagnosis to treatment to survivorship. Our research investments are enabling discoveries by establishing and growing key national scientific resources such as gold-standard ovarian cancer…" Full program description.
How much of Ovarian Cancer Canada's spending goes to programs?T1
Per its F2024 T3010, 58¢ of each dollar it spent went to programs (self-reported, not independently verified). Full figures.
How big is Ovarian Cancer Canada?T1
Its last-reported revenue was $6.4M (F2024), which places it in Charity Compass's $1M–$10M revenue band, alongside 9,072 other operating charities.
What it does — in its own words
Ongoing programs
Research: Investing in pan-Canadian and patient-centered research across the full continuum of ovarian cancer from prevention to diagnosis to treatment to survivorship. Our research investments are enabling discoveries by establishing and growing key national scientific resources such as gold-standard ovarian cancer models patient tissue banks biorepositories and a rare tumours database. Ovarian Cancer Canada is maximizing impact through discovery pre-clinical and clinical research and transforming lives through supporting interventional and pragmatic/real-world clinical trials. Influence … Show more
Research: Investing in pan-Canadian and patient-centered research across the full continuum of ovarian cancer from prevention to diagnosis to treatment to survivorship. Our research investments are enabling discoveries by establishing and growing key national scientific resources such as gold-standard ovarian cancer models patient tissue banks biorepositories and a rare tumours database. Ovarian Cancer Canada is maximizing impact through discovery pre-clinical and clinical research and transforming lives through supporting interventional and pragmatic/real-world clinical trials. Influence health system improvements: design and lead research initiatives (including the upcoming Canadian Experiences of Ovarian Cancer; research projects funded through the Ovarian Cancer Prevention Task Force Support for individuals living with ovarian cancer: • Offer education programs and provide information resources so that individuals living with ovarian cancer and those at high risk of developing the disease are empowered with the confidence knowledge and resources needed to be active and integrated participants in their care so they can make informed decisions that are aligned with their needs and values. • Provide and facilitate safe and inclusive opportunities for individuals living with ovarian cancer and those at high risk of developing the disease to connect and engage with others so they may feel less isolated and distressed a sense of collective strength and ultimately an improved quality of life.
New programs
To enhance ovarian cancer disease management through increased patient engagement and integration in their care OCC focused on developing new resources in order to broaden awareness and understanding of ovarian cancer encompassing risk factors prevention symptoms detection treatments and survivorship care. Understanding Ovarian Cancer: A Comprehensive Patient Guide – Developed by OCC in close partnership with a team of experts and those diagnosed this free guide supports and informs ovarian cancer patients and their loved ones at every stage of their ovarian cancer experience. At over… Show more
To enhance ovarian cancer disease management through increased patient engagement and integration in their care OCC focused on developing new resources in order to broaden awareness and understanding of ovarian cancer encompassing risk factors prevention symptoms detection treatments and survivorship care. Understanding Ovarian Cancer: A Comprehensive Patient Guide – Developed by OCC in close partnership with a team of experts and those diagnosed this free guide supports and informs ovarian cancer patients and their loved ones at every stage of their ovarian cancer experience. At over 230 pages print and electronic versions of these English and French guides can be ordered at https://ovariancanada.org/resources/support-resources Cancer centres across Canada have been provided with bookmarks with QR codes so ovarian cancer patients can receive the Guide when they need it most; at the time of diagnosis. Talking to Your Family Doctor About Ovarian Cancer - Ovarian cancer is a relatively rare cancer. There is no effective screening test no reliable diagnostic test and no 'red-flag' symptoms. Considering these challenges it can be difficult for patients to have an effective conversation with their family doctor. OCC developed a worksheet designed to help people identify and record their risk factors symptoms and family history so they can review this information with their primary care provider and make the best decisions possible about their care. There are opportunities to adapt this worksheet to individuals’ unique values preferences and experiences including conversation prompts related to: sexual trauma gender identity Indigenous culture learning styles and geographical distance from care. Talking to Your Doctor About Clinical Trials – This worksheet was developed to provide ovarian cancer patients with guidance on discussing clinical trials with their oncologists. It can be downloaded at https://ovariancanada.org/resources/talk-to-your-doctor-about-clinical-trials and used at appointments. This tool details the basics of a clinical trial and provides some questions patients can ask when speaking to their doctor. In addition to this worksheet a variety of companion resources have been developed and can be found on OCC’s website to help explain and dispel myths regarding clinical trials including Clinical Trial FAQ: The Basics; Finding a Clinical Trial; Is a Clinical Trial Right for You; and Participating in a Clinical Trial
Program descriptions from its F2024 T3010 filing, verbatim · self-reported · this is also the text our semantic search matches against. source ↗
Tier 1 — what we computed (open data)
From the charity's own F2024 T3010 filing. Self-reported; not independently verified. You can recompute every figure. New to these terms? Read what cents to the cause, overhead and reserves mean.
58¢
Per its F2024 T3010, 58¢ of each dollar spent went to programs. The rest ran the organization and raised money; higher is not automatically better.
Sector median: 89¢ across 55,155 computed charities; 87¢ among those its size ($1M–$10M).
this charity 58¢ · sector median 89¢ · all 55,155 computed charities
T3010 line 5000 ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗ · what this means
42%
Management, administration, and fundraising as a share of total spending. We treat 5–35% as the typical range; we state the figure, you judge.
T3010 line (5010 + 5020) ÷ 4950 · Self-reported on the T3010; not independently verified. source ↗ · what this means
0.7 yr
Years that cash, bank balances and investments on hand could cover program spending; liabilities and restricted funds are not netted out.
Charities its size ($1M–$10M, 9,072): median 0.5 yr; 43% hold under half a year. All operating charities: median 0.8 yr.
T3010 line (4100 + 4140) ÷ 5000 · Self-reported on the T3010; not independently verified. source ↗ · what this means
Total revenue
T1 · computed (open data)$6.4M
Last-reported total revenue.
T3010 line 4700 · Self-reported on the T3010; not independently verified. source ↗
Donor-funded
T1 · computed (open data)36%
Share of revenue from receipted donations.
T3010 line 4500 ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗
44%
Share of revenue from federal, provincial, and municipal sources.
T3010 line 4570 (or 4540+4550+4560) ÷ 4700 · Self-reported on the T3010; not independently verified. source ↗ · what this means
Where the money comes from
Shares of last-reported revenue, per its F2024 T3010. Self-reported; not independently verified.
Receipted donationsT1
36%
T3010 4500 ÷ 4700
GovernmentT1
44%
T3010 4570 (or 4540+4550+4560) ÷ 4700
Other revenueT1
21%
T3010 remainder ÷ 4700
Self-reported on the T3010; not independently verified. source ↗
Over the years
Every figure as filed at each fiscal period end, 2019–2024.
| Period end | Revenue | Cents to cause | Overhead | Reserves |
|---|---|---|---|---|
| 2019-03-31 | $3.4M | 61¢ | 37% | 0.1 yr |
| 2020-03-31 | $4.9M | 65¢ | 35% | 1 yr |
| 2021-03-31 | $5.4M | 128¢✱ | 33% | 1.1 yr |
| 2022-03-31 | $6.9M | 60¢ | 40% | 2.1 yr |
| 2023-03-31 | $6.2M | 58¢ | 42% | 1 yr |
| 2024-03-31 | $6.4M | 58¢ | 42% | 0.7 yr |
| trend |
Swipe sideways to see every column.
From its T3010 filings (CRA annual releases) · self-reported, not audited by us · when a period is restated in a later release, the newest figures are shown · ✱ = cents-to-cause outside the valid 0–100% range (filing error; not used in rankings). source ↗
★ Tier 2 — Charity Intelligence (analyst-reviewed)
Published ratings by Charity Intelligence Canada's analysts — a separate, human review. Shown as published, never blended into our computed figures.
Overall rating
★ T2 · Charity Intelligence★★★★
Charity Intelligence's 0–5 star overall rating.
Analyst-reviewed by Charity Intelligence; their methodology, shown as published. source ↗
Results reporting
★ T2 · Charity Intelligence—
Not reported in this filing: the return leaves out the lines this figure needs, so we show nothing rather than an estimate.
Analyst-reviewed by Charity Intelligence; their methodology, shown as published. source ↗
Demonstrated impact
★ T2 · Charity Intelligence—
Not reported in this filing: the return leaves out the lines this figure needs, so we show nothing rather than an estimate.
Analyst-reviewed by Charity Intelligence; their methodology, shown as published. source ↗
Similar charities
Same CRA category, revenue within 20× of this one, and the closest program descriptions in their own filings. A shortlist to compare, not a ranking.
- CANADIAN CANCER SURVIVOR NETWORK
OTTAWA, ON·revenue $650K
93¢to programs · T1
- Young Adult Cancer Canada Inc.
ST. JOHN'S, NL·revenue $1.1M2 of 5 stars, Charity Intelligence T2
—to programs · T1
- LUNG CANCER CANADA CANCER PULMONAIRE CANADA
TORONTO, ON·revenue $1.3M
89¢to programs · T1
- RETHINK BREAST CANCER CANADA
TORONTO, ON·revenue $1.2M4 of 5 stars, Charity Intelligence T2
78¢to programs · T1
- BLADDER CANCER CANADA
NORTH YORK, ON·revenue $1.2M4 of 5 stars, Charity Intelligence T2
44¢to programs · T1
Figures per each charity's F2024 T3010 · self-reported, not audited by us · ✱= that filing's expense lines don't reconcile · open a profile for sources and caveats.
Board of directors
12 directors reported · 12 of 12at arm's length
- Barrett, ErinDirectorarm's length
- Power, DavidTreasurer Board of Directorsarm's length
- Vanderhyden, BarbaraDirectorarm's length
- Greve Young, KarenChair of Board of Directorsarm's length
- Brunet, MichelDirectorarm's length
- Clark, DeborahDirectorarm's length
- Galloway, Victoria ADirectorarm's length
- Bugden, LydiaDirectorarm's length
- Veylan, RowenaDirectorarm's length
- Hollington, JenniferDirectorarm's length
- Sunley, Elizabeth (Liza)Directorarm's length
- King, AbrahamDirectorarm's length
From its F2024T3010 filing (public CRA record), as filed. “Arm's length” means not related to other officials by family or business ties. source ↗
Right of reply
This charity hasn't added a response yet. When it does, it appears here, beside the numbers, and is never removed. Represent this charity? Submit a response.
Verify everything: full public record on CharityData.ca ↗ · CRA charities listing ↗